NCT03878199 2025-09-15Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative NeoplasmsOhio State University Comprehensive Cancer CenterPhase 1/2 Completed12 enrolled